119 related articles for article (PubMed ID: 33617469)
21. Differentiating between benign follicular nodules and follicular neoplasms in thyroid liquid-based cytology preparations.
Suzuki A; Hirokawa M; Higuchi M; Takada N; Yamao N; Kuma S; Miyauchi A
Diagn Cytopathol; 2016 Aug; 44(8):659-64. PubMed ID: 27253911
[TBL] [Abstract][Full Text] [Related]
22. In vivo formation of gamma-H2AX and 53BP1 DNA repair foci in blood cells after radioiodine therapy of differentiated thyroid cancer.
Lassmann M; Hänscheid H; Gassen D; Biko J; Meineke V; Reiners C; Scherthan H
J Nucl Med; 2010 Aug; 51(8):1318-25. PubMed ID: 20660387
[TBL] [Abstract][Full Text] [Related]
23. Immunofluorescence analysis of DNA damage response protein p53-binding protein 1 in a case of uterine dedifferentiated leiomyosarcoma arising from leiomyoma.
Matsuda K; Akazawa Y; Yamaguchi Y; Mussazhanova Z; Kurohama H; Ueki N; Kohno M; Fukushima A; Kajimura I; Hiraki H; Matsuwaki T; Kawashita S; Kinoshita A; Nakashima M
Pathol Res Pract; 2019 Nov; 215(11):152640. PubMed ID: 31570279
[TBL] [Abstract][Full Text] [Related]
24. Role of pro-angiogenic marker galectin-3 in follicular neoplasms of thyroid.
Manivannan P; Siddaraju N; Jatiya L; Verma SK
Indian J Biochem Biophys; 2012 Oct; 49(5):392-4. PubMed ID: 23259327
[TBL] [Abstract][Full Text] [Related]
25. Value of thyroid specific peroxidase and Ki-67 stains in preoperative cytology for thyroid follicular tumors.
Maruta J; Hashimoto H; Yamashita H; Noguchi H; Noguchi S; Kobayashi TK; Tsuneoka H; Takahashi M
Diagn Cytopathol; 2015 Mar; 43(3):202-9. PubMed ID: 25195571
[TBL] [Abstract][Full Text] [Related]
26. Genomic instability in the epidermis induced by atomic bomb (A-bomb) radiation: a long-lasting health effect in A-bomb survivors.
Naruke Y; Nakashima M; Suzuki K; Kondo H; Hayashi T; Soda M; Sekine I
Cancer; 2009 Aug; 115(16):3782-90. PubMed ID: 19517458
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical expression of HBME-1 and galectin-3 in the differential diagnosis of follicular-derived thyroid nodules.
Abd-El Raouf SM; Ibrahim TR
Pathol Res Pract; 2014 Dec; 210(12):971-8. PubMed ID: 25041837
[TBL] [Abstract][Full Text] [Related]
28. [Expression of cytokeratin19, galectin-3 and HBME-1 in thyroid lesions and their differential diagnoses].
Teng XD; Wang LJ; Yao HT; Li J; Ding W; Yan LP
Zhonghua Bing Li Xue Za Zhi; 2004 Jun; 33(3):212-6. PubMed ID: 15256110
[TBL] [Abstract][Full Text] [Related]
29. Preoperative diagnosis of the follicular variant of papillary carcinoma of the thyroid: discrepancy between image and cytologic diagnoses.
Komatsu M; Hanamura N; Tsuchiya S; Seki T; Kuroda T
Radiat Med; 1994; 12(6):293-9. PubMed ID: 7724824
[TBL] [Abstract][Full Text] [Related]
30. Can the microRNA signature distinguish between thyroid tumors of uncertain malignant potential and other well-differentiated tumors of the thyroid gland?
Lassalle S; Hofman V; Ilie M; Bonnetaud C; Puisségur MP; Brest P; Loubatier C; Guevara N; Bordone O; Cardinaud B; Lebrigand K; Rios G; Santini J; Franc B; Mari B; Al Ghuzlan A; Vielh P; Barbry P; Hofman P
Endocr Relat Cancer; 2011 Oct; 18(5):579-94. PubMed ID: 21778212
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic value of liquid-based cytology with fine needle aspiration specimens for cervical lymphadenopathy.
Bandoh N; Goto T; Akahane T; Ohnuki N; Yamaguchi T; Kamada H; Harabuchi Y; Tanaka S; Nishihara H
Diagn Cytopathol; 2016 Mar; 44(3):169-76. PubMed ID: 26748563
[TBL] [Abstract][Full Text] [Related]
32. Discordance between phosphorylation and recruitment of 53BP1 in response to DNA double-strand breaks.
Harding SM; Bristow RG
Cell Cycle; 2012 Apr; 11(7):1432-44. PubMed ID: 22421153
[TBL] [Abstract][Full Text] [Related]
33. Clear Cell Variant of a Follicular Thyroid Tumor With Uncertain Malignant Potential: A Case Report.
Juhlin CC; Bränström R; Shabo I; Höög A
Int J Surg Pathol; 2019 May; 27(3):290-293. PubMed ID: 30370813
[TBL] [Abstract][Full Text] [Related]
34. Conventional Direct Smear Yields Diagnostic Indicators of Gastric-Type Mucinous Carcinoma Compared with Cytomorphological Features Identified by Liquid-Based Cervical Cytology.
Ryu A; Nagata S; Kubo C; Ueda Y; Tanada S; Idota A; Kamiura S; Honma K; Yamasaki T
Acta Cytol; 2021; 65(2):150-157. PubMed ID: 33176300
[TBL] [Abstract][Full Text] [Related]
35. Follicular thyroid lesions: is there a discriminatory potential in the computerized nuclear analysis?
Valentim FO; Coelho BP; Miot HA; Hayashi CY; Jaune DTA; Oliveira CC; Marques MEA; Tagliarini JV; Castilho EC; Soares P; Mazeto GMFS
Endocr Connect; 2018 Aug; 7(8):907-913. PubMed ID: 29973373
[TBL] [Abstract][Full Text] [Related]
36. Peroxisome proliferator-activated receptor gamma expression in follicular-patterned thyroid lesions. Caveats for the use of immunohistochemical studies.
Gustafson KS; LiVolsi VA; Furth EE; Pasha TL; Putt ME; Baloch ZW
Am J Clin Pathol; 2003 Aug; 120(2):175-81. PubMed ID: 12931546
[TBL] [Abstract][Full Text] [Related]
37. Clinical impact of a cytological screening system using cyclin D1 immunostaining and genomic analysis for the diagnosis of thyroid nodules.
Teshima M; Tokita K; Ryo E; Matsumoto F; Kondo M; Ikegami Y; Shinomiya H; Otsuki N; Hiraoka N; Nibu KI; Yoshimoto S; Mori T
BMC Cancer; 2019 Mar; 19(1):245. PubMed ID: 30885146
[TBL] [Abstract][Full Text] [Related]
38. The in vivo dynamic interplay of MDC1 and 53BP1 at DNA damage-induced nuclear foci.
Mok MT; Henderson BR
Int J Biochem Cell Biol; 2012 Sep; 44(9):1398-409. PubMed ID: 22677490
[TBL] [Abstract][Full Text] [Related]
39. Is an Increase in Thyroid Nodule Volume a Risk Factor for Malignancy?
Nakamura H; Hirokawa M; Ota H; Kihara M; Miya A; Miyauchi A
Thyroid; 2015 Jul; 25(7):804-11. PubMed ID: 25872408
[TBL] [Abstract][Full Text] [Related]
40. How to handle borderline/precursor thyroid tumors in management of patients with thyroid nodules.
Kakudo K
Gland Surg; 2018 Aug; 7(Suppl 1):S8-S18. PubMed ID: 30175059
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
